Clinical significance of increased plasma concentration of macrophage colonystimulating factor in patients with angina pectoris
Tsutomu Saitoh, MDa,1,
Hiroshi Kishida, MDa,
Yayoi Tsukada, MDa,
Yumiko Fukuma, MDa,
Junko Sano, MDa,
Masahiro Yasutake, MDa,
Nagaharu Fukuma, MDa,
Yoshiki Kusama, MDa and
Hirokazu Hayakawa, MDa
a First Department of Internal Medicine, Nippon Medical School, Tokyo, Japan

View larger version (10K):
[in a new window]
|
Figure 1 Circulating MCSF concentrations in patients with UA, patients with SA and control subjects. ***p < 0.001 (by post hoc analysis).
|
|

View larger version (21K):
[in a new window]
|
Figure 2 Changes in the circulating MCSF concentration in patients with CAD and in control subjects. The plasma MCSF concentration increased in proportion to the number of diseased coronary arteries, giving a significant positive correlation between the MCSF concentration and the number of diseased coronary arteries (r = 0.328, p < 0.001). Co = control subjects.
|
|

View larger version (16K):
[in a new window]
|
Figure 3 Cumulative two-year cardiac event-free survival curves for patients with angina pectoris. The cardiac event-free rate in patients with an MCSF concentration 950 pg/ml is significantly lower than that in patients with an MCSF concentration <950 pg/ml (p < 0.001).
|
|
|